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It must be very difficult to serve on the committee to
select Nobel Prize winners—to have to select one or
two scientific advances amidst many outstanding dis-
coveries, to have to choose the two or three key investi-
gators (who may not be the most visible or most cited
ones), and to have to sift through many nominations
that extol the achievements of some candidates (but
overlook those of others). Nevertheless, the scientists
selected in recent years have consistently been ones
who have made outstanding contributions, and this
year’s decision to award the Nobel Prize for Chemistry
to Avram Hershko, Aaron Ciechanover, and Irwin Rose
for the discovery of the ubiquitin system is particularly
insightful and honors three biochemists whose seminal
work has altered modern biology.
For a long time, the physiological importance of intra-
cellular protein breakdown was not widely recognized,
and studies of this process were distinctly unfashion-
able. Today, undergraduates and even advanced high
school students learn that the levels of proteins in cells
are determined by the balance between their rates of
synthesis and degradation, and that many cellular pro-
cesses are regulated through the degradation of critical
components by the ubiquitin-proteasome pathway.
During the past 15 years, work of many investigators
has firmly established the key role of this pathway in
the control of cell growth, progression through the cell
cycle (Peters, 2002; Deshaies, 1999; Hershko and
Ciechanover, 1998), transcriptional regulation, apopto-
sis, immune responses (Ben-Neriah, 2002), and the
pathogenesis of many human diseases (Glickman and
Ciechanover, 2002; Sakamoto, 2002). For example, a
number of cancers are associated with either a failure
to degrade rapidly an oncoprotein or accelerated de-
gradation of a tumor suppressor (Huibregtse et al.,
1995; Guardavaccaro and Pagano, 2004; Kaelin, 2002),
while apoptosis is inhibited under normal conditions by
the selective destruction of various proapoptotic pro-
teins (Martin, 2004). In fact, most changes in cell com-
position, whether major, as occurs during cell differenti-
ation (Cook and Tyers, 2004), or limited, such as
modifications of synaptic properties (Ehlers, 2003;
Hegde and DiAntonio, 2002) or cell cycle transitions,
involve the selective destruction of certain cell compo-
nents and their replacement by others. Even the gross
loss of neuronal integrity in Wallerian degeneration
(Ehlers, 2004) and the marked loss of muscle mass re-
sulting from inactivity, fasting, sepsis, and cancer
cachexia results from a programmed activation of this
degradative process (Lecker et al., 2004; Sandri et al.,
2004).*Correspondence: alfred_goldberg@hms.harvard.eduIn addition to its fundamental role in cell regulation,
the ubiquitin-proteasome pathway serves as an essen-
tial quality control mechanism that selectively elimi-
nates misfolded or damaged proteins from the cytosol
and nucleus (Goldberg, 1972, 2003). A failure of this
process leads to the accumulation of aberrant proteins
within cells and appears to contribute to the pathogen-
esis of most of the major neurodegenerative diseases,
including Parkinson’s, Huntington’s, Alzheimer’s, and
ALS (Sherman and Goldberg, 2001; Johnston and Ma-
dura, 2004). Eukaryotic cells also use the ubiquitin-pro-
teasome pathway to rapidly destroy misfolded mem-
brane proteins (e.g., Alzheimer’s amyloid propeptide)
before they emerge from the endoplasmic reticulum
(Kostova and Wolf, 2003; Ahner and Brodsky, 2004). For
example, in cystic fibrosis patients, the mutated mem-
brane chloride transporter is recognized as misfolded,
removed from the endoplasmic reticulum, and rapidly
degraded. This degradative process also enables the
immune system to selectively eliminate virus-infected
or cancer cells, because peptides generated during the
breakdown of cell proteins are continually displayed on
MHC class I molecules on the surface of most cells
(Rock and Goldberg, 1999). If foreign peptides are dis-
played, the cells are recognized by cytolytic T cells as
potentially dangerous and are destroyed. Knowledge
about this degradative process has already yielded
practical benefits in medicine with the development of
an important new anticancer therapy, the proteasome
inhibitor Velcade (PS-341), which is already in wide use
for the treatment of multiple myeloma and is presently
in clinical trials against a number of other human can-
cers (Adams, 2004; Kisselev and Goldberg, 2001). It is
in fact difficult to identify an area of biomedical re-
search where protein degradation by the ubiquitin-pro-
teasome pathway is not of major importance and a
subject of active investigation.
The Ubiquitin-Proteasome Pathway
For these many reasons, it was widely anticipated that
a Nobel Prize in Physiology and Medicine would some-
day be awarded in recognition of discoveries about this
degradative process. In awarding the prize in Chemis-
try, however, the Nobel Committee chose to honor the
seminal discoveries of the role of ubiquitin in this path-
way and elucidation of the steps involved in its conju-
gation to proteins. This now classic work began when
Avram Hershko was an Associate Professor of Biochem-
istry at the Technion in Haifa, Israel, and had as his PhD
student Aaron Ciechanover. Together these MDs-turned
biochemists discovered that the small heat-stable pro-
tein, later identified as ubiquitin, functions as a cofactor
in the nonlysosomal pathway for protein breakdown
(Ciechanover et al., 1978). Through a collaboration with
Irwin Rose, an accomplished enzymologist at Fox Chase
Cancer Institute in Philadelphia, they subsequently de-
monstrated that ubiquitin becomes covalently linked to
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340proteins, and this modification targets them for rapid
odestruction (Figure 1).
eThe initial step in this process involves the ATP-
sdependent activation of ubiquitin to a thiol ester by the
Hubiquitin-activating enzyme E1 (Figure 2), which then
atransfers the highly reactive ubiquitin to one of the cell’s
e20 to 30 E2s or ubiquitin carrier proteins (Hershko and
nCiechanover, 1998; Glickman and Ciechanover, 2002).
FThe ubiquitin ligases or E3s bind specific protein sub-
estrates and thus confer substrate specificity to this pro-
pcess. The E3 then transfers the ubiquitin from the E2 onto
aan -amino group on a lysine on the protein substrate
fforming an unusual isopeptide bond in a T-shaped link-
page (in contrast to the genetically encoded linear link-
aages of amino acids formed on ribosomes). The same
pE3 then links additional ubiquitin molecules to the pre-
cceding ubiquitin, and when the isopeptide chain con-
tains more than four ubiquitin molecules (Thrower et al.,
2000), the substrate is targeted to the 26S proteasome D
a(Figure 3), where it is rapidly degraded to small pep-
tides (Pickart and Cohen, 2004; Voges et al., 2000). Sev- T
oeral different families of E3s have now been identified
(Huibregtse et al., 1995; Jackson et al., 2000; Deshaies, i
t1999; Lorick et al., 1999; Weissman, 2001), and it is now
recognized that mammalian cells contain between 500 i
hand 1000 different ubiquitin ligases, which function with
specific E2s to give exquisite selectivity to protein de- b
cgradation, as well as to other ubiquitin-dependent pro-
cesses (see below). C
gE3s generally recognize small domains of the sub-
strate (often called “degrons”) (Varshavsky, 1997). For c
(example, a number of important E3s bind peptide se-
quences only when they are phosphorylated (Skowyra d
net al., 1997). This mechanism—phosphorylation by a
specific kinase triggering selective ubiquitination and s
wdegradation of an enzyme or regulatory protein—under-
lies most of the irreversible steps in the cell cycle (De- (
ashaies, 1999; Jackson et al., 2000), and also the onset
of the inflammatory response, where TNF or other in- c
tflammatory mediators trigger the phosphorylation and
rapid degradation of IκB, the inhibitor of NFκB tran- o
gscription factor (Palombella et al., 1994; Ben-Neriah,
2002). A variety of cellular responses involve the selec- o
tive degradation of a critical regulatory protein by a
highly specific ubiquitin ligase, and the loss of a spe- s
icific E3 can have consequences on brain function asd
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Figure 1. ATP Serves Multiple Functions in the Ubiquitin-Protea-
some Pathway
t
aivergent as mental retardation and Parkinson’s dis-
ase (Johnston and Madura, 2004). One example of
ajor importance in physiology and medicine is in the
ranscriptional adaptation of cells to anoxia (Kaelin,
002; Krek, 2000). When cells are well oxygenated, a
pecific proline residue in the transcription factor HIF
ecomes oxidized to a hydroxyproline, and this minor
odification is recognized by a specific E3. Conse-
uently, in normal cells, the HIF is rapidly degraded and
nable to function, but in anoxic cells, this modification
an not occur; consequently, HIF is stable in ischemic
ells and transcribes genes for erythroprotein, VEGF,
nd glycolytic enzymes. This adaptation is especially
mportant for the growth of cancer cells, some of which
e.g., renal cell carcinomas, pheochromocytomas) lose
his specific E3 (Kaelin, 2002), which thus functions as
tumor suppressor.
These various advances have resulted from the work
f many talented biochemists and cell biologists. How-
ver, our present understanding of the ubiquitin-protea-
ome pathway stems from the initial elucidation by
ershko, Ciechanover, and Rose of the biochemical re-
ctions involved in protein ubiquitination, as well as the
legant genetic analysis of this process and its compo-
ents by Varshavsky and coworkers (Varshavsky, 1997;
inley et al., 1984), which stimulated much wider inter-
st in this area. The subsequent discovery of the 26S
roteasome (Figure 3) (Hough et al., 1987; Waxman et
l., 1987) and the recent identification of many new
unctions of this pathway, largely through the use of the
harmacological inhibitors of the proteasome (Rock et
l., 1994; Kisselev and Goldberg, 2001), have led to our
resent understanding of this pathway and its biologi-
al importance.
iscovery of the Nonlysosomal Pathway
nd of Ubiquitin Conjugation
he work of Hershko and colleagues initially focused
n trying to understand an anomalous observation that,
f real, appeared to be an important clue to the iden-
ification of the site and biochemical mechanisms for
ntracellular protein degradation. Several investigators
ad observed that inhibitors of ATP production could
lock protein breakdown and suggested that this pro-
ess required ATP (Goldberg and St. John, 1976;
iechanover, 2004), which was a very surprising sug-
estion, because protein hydrolysis is a thermodynami-
ally favored reaction, and all proteases known then
e.g., digestive or lysosomal proteases) functioned in-
ependently of ATP. In fact, these reports actually were
ot taken seriously by most biochemists at the time,
ince they involved use of metabolic poisons and could
ell have been explained by various indirect effects
e.g., ATP might be required for synthesis of new prote-
ses or to maintain the redox state or ionic milieu in the
ells). Alternatively, these observations could indicate
hat ATP was required for the function of lysosomes
r to transport proteins into this organelle, which was
enerally assumed to be the site for intracellular prote-
lysis (de Duve and Wattiaux, 1966).
Consequently, in the early 1970s, the present author
pent several years critically analyzing this requirement
n intact cells, only to finally establish that ATP was truly
Essay
341Figure 2. The Three Steps in the Formation of a Ubiquitin Chain on
a Protein Substraterequired for an early step in the breakdown process
(Goldberg et al., 1975; Goldberg and St. John, 1976).
We had chosen to study this process in reticulocytes
and E. coli, specifically because they lack lysosomes,
and using extracts of these cells, we eventually were
able to demonstrate the existence of a nonlysosomal
proteolytic system that utilized ATP to catalyze the
rapid degradation of misfolded cell proteins (Etlinger
and Goldberg, 1977). The roles of ATP and the respon-
sible degradative machinery were then amenable to
biochemical analysis. Using such preparations from re-
ticulocytes, Hershko, Ciechanover, and Rose discov-
ered the involvement of ubiquitin and the critical role of
ATP hydrolysis in providing the energy necessary for
covalent linkage of ubiquitin to the substrate. (For a
fuller account of these early developments, see the
press release of the Royal Swedish Academy of Sci-
ences [Nobelprize.org] or the recent review by Ciecha-
nover [2004]).
Since my lab had laid the basis for their seminal
work, but missed the discovery of ubiquitin, I am in a
unique position to appreciate the truly innovative char-
acter of their discoveries, and how it provided a new
conceptual framework for the studies of protein turn-
over, and especially the “selectivity problem.” Since the
initial recognition by Schimke and coworkers in the
1960s that different proteins in cells are degraded at
distinct rates and that rapid degradation is a key fea-
ture of highly regulated enzymes (Schimke and Doyle,
1970), the biochemical basis of this selectivity and for
the selective degradation of misfolded proteins (Gold-
berg, 1972) was an active topic of speculation amongst
the few individuals investigating this area. This rapid
degradation of rate-limiting enzymes and misfolded
proteins indicated that protein half-lives must be deter-
mined by their tertiary or primary sequences (Goldberg
and Dice, 1974) and seemed inconsistent with degrada-
tion within lysosomes. It is now clear that this selectiv-ity reflects the existence in cells of very many highly
specific E3s.
However, the importance of ubiquitin was not imme-
diately apparent after the initial reports from Hershko
and Ciechanover; in fact, at the time, we (and others)
were initially atheistic concerning the “ubiquitin hy-
pothesis,” but then we became agnostic, and soon we
were firm believers. Our conversion came about due to
their subsequent series of elegant papers, many with I.
Rose, that appeared in the early 1980s and defined the
enzymatic steps in the ubiquitination process (Hershko
et al., 1980, 1981, 1983, 1984; Ciechanover et al., 1978,
1980, 1981). Amongst biologists, the contributions of
Hershko and Ciechanover are widely recognized be-
cause of their major roles in the subsequent de-
velopment of this area and their useful reviews. Rose’s
contributions have been less widely appreciated, but
elucidation of the ubiquitination pathway required a so-
phistication in enzymology that few biologists possess
or appreciate, such as their use of a pyrophosphate
exchange assay for the enzyme E1, defining the key
roles of thiol esters in ubiquitin activation (enzymatic
reactions resembling those involved in fatty acid oxida-
tion), their discovery of the isopeptidases that disas-
semble ubiquitin chains, or the synthesis of ubiquitin-
aldehyde to inhibit this process, and biochemical
mechanisms. These major contributions were certainly
made possible by Rose’s enzymological expertise, and
it is a sign of Hershko’s cleverness to seek out such a
knowledgeable collaborator.
However, there was also an important element of ser-
endipity in this story. When the Israeli workers came to
work with Rose at the Fox Chase Institute in Philadel-
phia, a neighboring lab was studying the function of
histone A24, an unusual histone, which Harris Busch
and colleagues had shown consists of a histone linked
to the polypeptide ubiquitin through an isopeptide link-
age (Goldknopf and Busch, 1977). Familiarity with the
work of their neighbors enabled Wilkinson and Haas
(two postdocs in Rose’s lab) to show that ubiquitin cor-
responded to the heat-stable polypeptide that Hershko
and Ciechanover had implicated in proteolysis (Wilkin-
son et al., 1980), and this recognition led to a unifying
hypothesis by the three prize winners that ubiquitin li-
gation to proteins targets them for destruction (Hershko
et al., 1980), as they subsequently demonstrated.
The 26S Proteasome and a Fuller Understanding
of the ATP Requirement for Proteolysis
Ironically, it soon became clear that ubiquitin conjuga-
tion does not explain the ATP requirement for intracellu-
lar proteolysis, and further exploration of this require-
ment led to a much fuller understanding of this pathway.
Ubiquitin first appeared during evolution with the ap-
pearance of eukaryotes, presumably to provide greater
selectivity and regulation to the degradative process. In
prokaryotes and their descendants, mitochondria and
chloroplasts (Desautels and Goldberg, 1982), protein
breakdown shows a similar ATP dependence (Goldberg
and St. John, 1976), although they lack ubiquitin. In
fact, for this reason, we were initially slow to believe
in ubiquitin conjugation as the explanation of the ATP
requirement, especially since in 1980 we discovered
Neuron
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ATP to Unfold and Translocate the Substrate into the 20S Core m
Particle for Degradation
This figure was modified from an electron microscopic tomograph
of the 26S proteasome kindly provided by W. Baumeister. O
a
Mthat, in bacteria, the energy requirement for selective
tproteolysis was due to the involvement of a new kind
fof proteolytic enzyme that digests proteins and ATP in
clinked reactions without any covalent tagging of the
fsubstrate (Chung and Goldberg, 1981; Chung, 1993;
hGottesman, 1996). Such ATP-hydrolyzing proteases are
cmultisubunit complexes, many times larger than typical
cproteases, and prokaryotes and mitochondria contain
tseveral such enzymes. Thus, two opposite explana-
mtions for the ATP requirement for intracellular proteoly-
esis emerged at about the same time, and subsequent
swork established that both mechanisms function in the
aubiquitin-dependent pathway.
tBy the mid-1980s, it became clear even that after
pproteins are ubiquitinated, ATP is still necessary for
ttheir breakdown (Tanaka et al., 1983; Hershko et al.,
k1984), and several years later, the 26S proteasome (Fig-
sure 3), the very large ATP-dependent proteolytic com-
oplex that degrades ubiquitinated proteins, was iden-
2tified (Hough et al., 1987; Waxman et al., 1987). This
ohuge molecular machine functions in analogous ways
nto the ATP-dependent proteases and proteasomes in
tprokaryotes (Pickart and Cohen, 2004). They utilize the
Tenergy in ATP to unfold globular proteins and to trans-
rlocate them into an internal proteolytic chamber (i.e.,
tthe 20S core proteasome) in which protein hydrolysis
Moccurs in an isolated environment away from valuable
Scellular components (Pickart and Cohen, 2004; Bena-
nroudj et al., 2003; Voges et al., 2000).
mMore recent work has indicated that ATP is also nec-
cessary for additional steps that are critical in the re-
tcognition of substrates for ubiquitination. As noted
mabove, many regulatory proteins are marked for ubiqui-
vtination by specific kinases, which means that their
abreakdown requires ATP in the very first step. In addi-
ttion, the selective degradation of mutant or misfolded
tproteins in the cytosol or ER, including various proteins
rimportant in human diseases (CFTR, hyperphosphory-
ilated tau), occurs through a collaboration between
aubiquitin ligases and the molecular chaperones, espe-
cially Hsp70 and 90, which selectively bind the abnor- eal species and in the presence of ATP release them
or ubiquitination by the specific E3, e.g., CHIP (Cyr et
l., 2002; Murata et al., 2001). Also, eukaryotic cells uti-
ize a specific ATPase complex (p97) to extract mis-
olded secretory proteins from the ER for ubiquitination
nd degradation in the cytosol (Kostova and Wolf,
003; Ahner and Brodsky, 2004). Finally, ATP depletion
f cells (as done in the early experiments of Hershko
nd Ciechanover) causes disassembly of the 26S pro-
easome and of its 19S regulatory complex, and one
unction of ATP in the extracts (and perhaps also in vivo)
s to support the reassembly of the 26S proteasome
Imai et al., 2003; Eytan et al., 1989; Driscoll and Gold-
erg, 1990). In any case, it is noteworthy that attempts
o understand a biochemical anomaly—why a thermo-
ynamically favored process should require metabolic
nergy—has led to the discovery of novel biochemical
achinery and a wealth of new biological insights.
ther Functions of Ubiquitin
nd the Ubiquitin-like Proteins
ore recently, the postsynthetic modification of pro-
eins by linkage to ubiquitin has been discovered to
unction as a key marking step in other cellular pro-
esses not involving the proteasome (Pickart, 2001). In
act, surprisingly, ubiquitin and ubiquitin-like proteins
ave recently been shown to play a key role in the in-
orporation of proteins into the lysosome, both endo-
ytosed proteins and cytosolic proteins engulfed in au-
ophagic vacuoles. Ligation of a single ubiquitin to
embrane receptors or transport proteins leads to their
ndocytosis and targets them for degradation by lyso-
omes (Hicke, 2001; Marmor and Yarden, 2004; Holler
nd Dikic, 2004). The formation on an intracellular pro-
ein of a different type of ubiquitin chain than causes
roteasomal degradation (i.e., ones involving isopep-
ide linkages to different lysines on the ubiquitin) are
ey events in the repair of damaged DNA and in certain
ignal transduction cascades, including the induction
f the inflammatory response by TNFa (Deng et al.,
000). In addition, eukaryotes have evolved a number
f ubiquitin homologs, other small proteins (with arcane
ames like Sumo, Nedd8, or ISI15) that also get ligated
o specific protein substrates through similar reactions.
hese modifications serve important physiological
oles that are different from those of ubiquitin conjuga-
ion (Schwartz and Hochstrasser, 2003; Johnson, 2004;
izushima et al., 2003); for example, conjugation to
umo targets proteins to the nuclear envelope and
uclear pore complex, and conjugation of NedD8 to
ultisubunit ubiquitin ligases (e.g., SCF complexes)
auses their activation, while ligation of the atg pro-
eins, of atg8 to a membrane protein and atg12 to a
embrane lipid, triggers the formation of autophagic
acuoles during cell starvation and apoptosis (Ohsumi
nd Mizushima, 2004). The conjugation of each ubiqui-
in-like protein involves activation by a specific E1, its
ransfer to a specific E2, and covalent ligation to lysine
esidues on the regulated proteins. Thus, the biochem-
stry of ubiquitination, recognized by this award, actu-
lly plays more ubiquitous roles in the functioning of
ukaryotic cells than ubiquitin itself.
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This Nobel Prize is unusual in an additional respect.
This prize represents the first awarded to Israeli scien-
tists for work in Israel, and it is indeed rare, perhaps
unprecedented, for outstanding research of an experi-
mental nature to originate in a small country with lim-
ited resources, especially one where frequent wars and
military challenges make enormous demands on its re-
sources and its citizens. Nevertheless, important con-
tributions to our knowledge about protein breakdown
and to other areas of cell biology continue to emerge
from Israeli laboratories to the benefit of biomedical
science worldwide.
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